Peralta, Sergio

Publishing since 2006 (Baby)

Has published 13 publications in 4 years

Number of publications published per year by Peralta, Sergio. (Source : PubMed)

Distribution of publications types for Peralta, Sergio. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

Peralta S, Cottone C, Doveri T, Almasio PL, Craxi A. Small intestine bacterial overgrowth and irritable bowel syndrome-related symptoms: experience with Rifaximin. World J. Gastroenterol. 2009;15;21
Prat A, Parera M, Adamo B, Peralta S, Perez-Benavente MA, Garcia A, Gil-Moreno A, Martinez-Palones JM, Baselga J, del Campo JM. Risk of recurrence during follow-up for optimally treated advanced epithelial ovarian cancer (EOC) with a low-level increase of serum CA-125 levels. Ann. Oncol. 2009;20;2
Cammà C, Petta S, Di Marco V, Bronte F, Ciminnisi S, Licata G, Peralta S, Simone F, Marchesini G, Craxì A. Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis. Hepatology 2009;49;1
Macarulla T, Ramos FJ, Elez E, Capdevila J, Peralta S, Tabernero J. Update on novel strategies to optimize cetuximab therapy in patients with metastatic colorectal cancer. Clin Colorectal Cancer 2008;7;5
Capdevila J, Elez E, Peralta S, Macarulla T, Ramos FJ, Tabernero J. Oxaliplatin-based chemotherapy in the management of colorectal cancer. Expert Rev Anticancer Ther 2008;8;8
Felip E, Rojo F, Reck M, Heller A, Klughammer B, Sala G, Cedres S, Peralta S, Maacke H, Foernzler D, Parera M, Möcks J, Saura C, Gatzemeier U, Baselga J. A phase II pharmacodynamic study of erlotinib in patients with advanced non-small cell lung cancer previously treated with platinum-based chemotherapy. Clin. Cancer Res. 2008;14;12
Muñoz E, Prat A, Adamo B, Peralta S, Ramón y Cajal S, Valverde C. A rare case of malignant solitary fibrous tumor of the spinal cord. Spine 2008;33;12
Prat A, Parera M, Peralta S, Perez-Benavente MA, Garcia A, Gil-Moreno A, Martinez-Palones JM, Roxana I, Baselga J, Del Campo JM. Nadir CA-125 concentration in the normal range as an independent prognostic factor for optimally treated advanced epithelial ovarian cancer. Ann. Oncol. 2008;19;2
Di Marco V, Almasio PL, Ferraro D, Calvaruso V, Alaimo G, Peralta S, Di Stefano R, Craxì A. Peg-interferon alone or combined with ribavirin in HCV cirrhosis with portal hypertension: a randomized controlled trial. J. Hepatol. 2007;47;4
Kohn A, Daperno M, Armuzzi A, Cappello M, Biancone L, Orlando A, Viscido A, Annese V, Riegler G, Meucci G, Marrollo M, Sostegni R, Gasbarrini A, Peralta S, Prantera C. Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up. Aliment. Pharmacol. Ther. 2007;26;5

[ See timeline ] [ See all publications ]

h=5

means that Peralta, Sergio has 5 papers cited a least 5 times - methodology

Key figures

13 pub in 4 years
3.3 publications/year
best year 2008 with 5 pub
h-index 5 with 13 pub
h-ratio : 38 %

See Timeline

Ranking

It's me !

Click here if you are
Peralta, Sergio.

Most frequent Journals

J Chemother (11x)
Ann. Oncol. (3x)
Aliment. Pharmacol. Ther. (2x)
Clin. Cancer Res. (1x)
World J. Gastroenterol. (1x)

Main affiliation

Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.

Latest co-workers

Adamo B Almasio PL Baselga J Capdevila J Craxì A Di Marco V Elez E Felip E Garcia A Gil-Moreno A Macarulla T Martinez-Palones JM Parera M Perez-Benavente MA Prat A Ramos FJ Simone F Tabernero J Valverde C Vázquez-Escamilla J

Back to HepaTop

Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.